tiprankstipranks
Solesence (SLSN)
NASDAQ:SLSN
US Market
Want to see SLSN full AI Analyst Report?

Solesence (SLSN) Earnings Dates, Call Summary & Reports

45 Followers

Earnings Data

Report Date
Aug 18, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
Last Year’s EPS
0.04
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 12, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call presents a mixed but constructive picture: near-term financial results were pressured by shipment delays and investments tied to the Transform and Transcend initiative (revenue down ~11%, net loss and negative adjusted EBITDA), but key positives include a 300-basis-point gross margin improvement to 26%, a $47M shipped + open orders book, new proprietary technology launches (Chromalum and WHSPR), completed co-marketing activations with brand partners, and a clear operational roadmap (SIOP, shift changes, facility consolidation) with reiterated guidance including a 30% gross profit floor and a plan to return to double-digit EBITDA margins by year-end. Given the balance of material execution risks and encouraging operational and commercial progress, the tone is cautiously optimistic but transitional.
Company Guidance
Solesence reiterated its 2026 guidance under the Transform and Transcend plan, establishing a 30% gross profit margin floor for the year and targeting a return to double‑digit (≥10%) EBITDA margins by year‑end, funded by labor‑efficiency gains, SIOP/inventory improvements and a 6‑figure annual facility‑consolidation savings; Q1 2026 results included $13.0M revenue (vs. $14.6M Q1 2025), gross margin up 300 basis points to 26%, net loss of $0.8M (vs. net income $0.08M prior year) and adjusted EBITDA loss of $107k (vs. +$609k prior year), with shipped and open orders totaling $47M, continued >50% CAGR over the past six years, >5× market‑cap uplift since NASDAQ uplist, two new technology launches (Chromalum, WHSPR), four co‑marketing activations completed, and the company saying it is on track with implementation across 3 of 4 strategic pillars.
Gross Margin Improvement
Gross margin increased by 300 basis points to 26% in Q1 2026 (up from ~23% a year ago), driven by improved labor efficiency and elimination of product quality-related waste.
Healthy Shipped + Open Orders
Shipped and open orders totaled $47.0 million, representing a sizable forward-looking book of business to be delivered within the year.
New Proprietary Technologies Launched
Launched two proprietary technologies, Chromalum and WHSPR, expanding product capabilities (SPF-infused hybrids) and opening adjacencies such as hair and scalp care.
Long-Term Growth Track Record and Market Milestones
Over the past 6 years the company grew at a compounded annual rate of over 50%, uplisted to NASDAQ and increased market capitalization by more than 5x.
Operational Initiatives Underway
Implemented updated shift structure and lean-manufacturing training; progressing SIOP implementation and inventory reductions; facility consolidation expected to deliver six-figure annual savings.
Commercial Partnerships and Co-Marketing Progress
Completed 4 co-marketing activations with brand partners (including Color Science, BloomAX and Seal), strengthening strategic relationships and product-level performance.
Reiterated Full-Year Targets and Path to Profitability
Management reiterated annual guidance (30% floor for gross profit margins) and remains on track to return to double-digit EBITDA margins by year-end as operational improvements take hold.

Solesence (SLSN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SLSN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 18, 2026
2026 (Q2)
- / -
0.037
May 12, 2026
2026 (Q1)
- / -
0.001
Mar 31, 2026
2025 (Q4)
- / -0.01
0.001-1200.00% (-0.01)
Nov 11, 2025
2025 (Q3)
- / -0.02
0.042-138.10% (-0.06)
Jul 31, 2025
2025 (Q2)
- / 0.04
0.015146.67% (+0.02)
May 05, 2025
2025 (Q1)
- / <0.01
0.015-93.33% (-0.01)
Mar 26, 2025
2024 (Q4)
- / >-0.01
-0.04381.40% (+0.03)
Oct 30, 2024
2024 (Q3)
- / 0.04
-0.029244.83% (+0.07)
Aug 06, 2024
2024 (Q2)
- / 0.01
0.007114.29% (<+0.01)
Apr 23, 2024
2024 (Q1)
- / 0.01
-0.023165.22% (+0.04)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SLSN Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 12, 2026
$1.50$1.24-17.33%
Mar 31, 2026
$0.90$0.95+5.33%
Nov 11, 2025
$2.81$2.13-24.20%
Jul 31, 2025
$3.43$2.78-18.95%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Solesence (SLSN) report earnings?
Solesence (SLSN) is schdueled to report earning on Aug 18, 2026, After Close (Confirmed).
    What is Solesence (SLSN) earnings time?
    Solesence (SLSN) earnings time is at Aug 18, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SLSN EPS forecast?
          Currently, no data Available